Епідеміологічні дані, етіологія, патогенез, фактори ризику, клінічні прояви, сучасні методи діагностики і лікування, прогнозування перебігу хронічної лімфоцитарної лейкемії

Eichhorst B., Robak T., Montserrat E. et al. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. No. 32(1). 2020. Р. 23-33. URL: https://doi.org/10.1016/j.annonc.2020.09.019.

Shvidel L, Berrebi A. Pitting new treatments for chronic lymphocytic leukemia against old ones: how do they fare? Expert Rev Hematol. No. 9 (3). 2016. Р. 245-254.

Dokic M., Urosevic I., Savic I. et al. A case of chronic lymphocytic leukaemia occurring during treatment of chronic myeloid leukaemia. Indian J Hematol Blood Transfus. No. 32 (Suppl 1). 2016. Р. 156-158.

Nabhan C., Rosen S. T. Chronic lymphocytic leukemia: a clinical review. JAMA. No. 312 (21). 2014. Р. 2265-2276.

Mertens D., Stilgenbauer S. Prognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches? J Clin Oncol. No. 32 (9). 2014. Р. 869-872.

24 конгрес Європейської гематологічної асоціації (EHA) відбувся 13-16 червня в місті Амстердам. URL: https://aoncohem.com.ua/24-konhres-evropeiskoi-hematolohichnoi- asotsiatsii-eha-vidbuvsia- 13-16-chervnia-v-misti-amsterdam.html.

Лімфопроліферативні захворювання. URL: http://lympho.com.ua/2019/06/10/ limfoproliferativni-zahvoryuvannya/.

Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспеціалізованої) медичної допомоги «Хронічний лімфоїдний лейкоз» : Наказ МОЗ України «Про затвердження та впровадження медико--технологічних документів зі стандартизації медичної допомоги при хронічному лімфоїдному лейкозі» від 12.05.2016 р. № 439. URL: https://www.dec.gov.ua/wp-content/uploads/2019/11/2016_439_ ykpmd_hll.pdf.

Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспеціалізованої) медичної допомоги: множинна мієлома» : Наказ МОЗ України «Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при множинній мієломі» від 02.11.2015 р. № 710. URL: https://dec.gov.ua/wp-content/uploads/images/dodatki/2015_710_MM/2015_710_YKPMD_MM.pdf.

Катер Арнон. Дослідження MURANO щодо схеми застосування венетоклаксу з ритуксимабом. Сучасні підходи до діагностики та лікування лімфопроліферативних захворювань: матеріали XII науково-практичної конференції з міжнародною участю (м. Київ, 1-2 жовтня 2020 р.). URL:https://www.clinicaloncology.com.ua/article/28613/

daj dzhest-xii-naukovo-praktichno%d 1%97-konferenczi%d 1%97-z-mizhnarodnoyu-uchastyu- suchasni-pidhodi-do-diagnostiki-ta-likuvannya-limfoproliferativnih-zahvoryuvan.

References

Kriachok, I. A., & Aleksyk, O.M. (n. d.). Limfoproliferatyvni zakhvoriuvannia [Lymphoproliferative diseases]. Retrieved from https://compendium.com.ua/uk/tutorials-uk/ onkologiya/rozdil-18-limfoproliferativni-zahvoryuvannya/ [in Ukrainian].

Lukavetskyi, L.M. (2020). Khronichna limfotsytarna leikemiia: vid rozpachu do nadii [Chronic lymphocytic leukemia: from despair to hope]. Onkolohiia. Hematolohiia. Khimioterapiia - Oncology. Hematology. Chemotherapy, 1 (62), 16-17. Retrieved from https://health-ua.com/ article/50055-hronchna-lmfotcitarna-lejkemya-vdrozpachu-donad [in Ukrainian].

Svintsitskyi, A., & Haievski, P. (2018-2019). Khronichnyi limfotsytarnyi leikoz/limfoma z malykh limfotsytiv [Chronic lymphocytic leukemia/lymphoma from small lymphocytes]. Vnutrishni khvoroby. Pidruchnyk, zasnovanyi na pryntsypakh dokazovoi medytsyny. - Internal diseases. A textbook based on the principles of evidence-based medicine. Krakiv: Praktychna medytsyna. Retrieved from https://empendium.com/ua/manual/chapter/B72.VI.H.1.1 [in Ukrainian].

Kriachok, I. (2023a). KhLL: evoliutsiia tsilei dlia patsiientiv ta pidkhodiv do likuvannia [CLL: evolving patient goals and treatment approaches]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XV naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XV scientific and practical conference with international participation. Retrieved from https://www.aoncohem.online/_files/ugd/e1115a_ a8870a0b81ba4c1c92caa67f964884bf.pdf [in Ukrainian].

Kriachok, I.A. (2023b). Yaki vyklyky sohodni vynykaiut na shliakhu patsiienta z KhLL v Ukraini shche do pochatku likuvannia? [What challenges are faced by a patient with CLL in Ukraine today even before treatment begins?]. Diahnostyka khronichnoi limfotsytarnoi leikemii: vebinar mizhnarodnoi shkoly onkohematolohii z profesorom Irynoiu Kriachok - Diagnosis of chronic lymphocytic leukemia: webinar of the International School of Hematology with Professor Iryna Kryachok. Retrieved from https://health-ua.com/article/74948-mzhnarodna-shkola- onkogematolog-zprofesorom-rinoyu-kryachok-dagnostika-hron [in Ukrainian].

Kriachok, I.A., Klymenko, S.V., Tytorenko, I.B., & Lukavetskyi, L.M. (2023). Innovatsiini stratehii v likuvanni khronichnoi limfotsytarnoi leikemii u patsiientiv hrupy vysokoho ryzyku: rol tarhetnykh preparativ [Innovative strategies in the treatment of chronic lymphocytic leukemia in high-risk patients: the role of targeted drugs]. Suchasni perspektyvy v likuvanni patsiientiv z V-klitynnoiu khronichnoiu leikotsytarnoiu leikemiieiu: satelitnyi sympozium - Modern perspectives in the treatment of patients with B-cell chronic leukocyte leukemia: satellite symposium. Retrieved from https://health-ua.com/article/73720-nnovatcjn-strateg-vlkuvann- hronchno-lmfotcitarno-lejkem-upatcntv-grupi-viso [in Ukrainian].

Kriachok, I. (2022). Suchasni pidkhody do likuvannia retsydyvnykh ta refrakternykh form KhLL. [Modern approaches to the treatment of recurrent and refractory forms of CLL]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XIV naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XIV scientific and practical conference with international participation. Retrieved from https://health-ua.com/ article/72113-perehd-na-nov-standarti-dagnostiki-taproriv-ulkuvann-patcntv-zhronchnim-lmf [in Ukrainian].

Kriachok, I. (2020). Likuvannia patsiientiv z retsydyvnym/refrakternym perebihom KhLL zghidno iz suchasnymy natsionalnymy standartamy - chy my robymo vse mozhlyve? [Treatment of patients with relapsed/refractory CLL according to current national standards - are we doing our best?]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XII naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XII scientific and practical conference with international participation. Retrieved from https://www.clinicaloncology.com.ua/article/28613/dajdzhest-xii-naukovo-praktichno%d1%97- konferenczi%d1%97-z-mizhnarodnoyu-uchastyu-suchasni-pidhodi-do-diagnostiki-ta-likuvannya- limfoproliferativnih-zahvoryuvan [in Ukrainian].

Kriachok, I.A. (2019). Khronichna limfotsytarna leikemiia vysokoho ryzyku - chas dlia zminy paradyhmy likuvannia [High-risk chronic lymphocytic leukemia - time to change the treatment paradigm]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy IX naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the IX scientific and practical conference. Retrieved from https://health-ua.com/article/43379-mozhlivost-brutinbu-v-lkuvann-patcntv-z-hronchnim- lmfodnim-lejkozom-talmfom [in Ukrainian].

Klymenko, S. (2023a). Molekuliarni ta klitynni mekhanizmy dii preparativ tarhetnoi terapii. Yak tse pratsiuie? [Molecular and cellular mechanisms of action of targeted therapy drugs. How does it work?]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XV naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XV scientific and practical conference with international participation. Retrieved from https://www.aoncohem.online/_files/ugd/en15a_a8870a0b81ba4c1c92caa67f964884bf.pdf [in Ukrainian].

Klymenko, S.V. (2023b). Nespryiatlyvi faktory perebihu ta alhorytmy henetychnoi diahnostyky KhLL [Unfavorable course factors and algorithms for genetic diagnosis of CLL]. Diahnostyka khronichnoi limfotsytarnoi leikemii: vebinar mizhnarodnoi shkoly onkohematolohii z profesorom Irynoiu Kriachok - Diagnosis of chronic lymphocytic leukemia: webinar of the International School of Hematology with Professor Iryna Kryachok. Retrieved from https://health- ua.com/article/74948-mzhnarodna-shkola-onkogematolog-zprofesorom-rinoyu-kryachok- dagnostika-hron [in Ukrainian].

Klymenko, S. (2022). Pidkhody do likuvannia KhLL z vpershe vstanovlenym diahnozom

[Approaches to the treatment of newly diagnosed CLL]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XIV naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of

lymphoproliferative diseases: materials of the XIV scientific and practical conference with international participation. Retrieved from https://health-ua.com/article/72113-perehd-na-nov- standarti-dagnostiki-taproriv-ulkuvann-patcntv-zhronchnim-lmf [in Ukrainian].

Lukavetskyi, L. (2023). Molekuly novoho pokolinnia - krok do universalnosti v terapii

khronichnoi limfotsytarnoi leikemii [Molecules of the new generation are a step towards universality in the therapy of chronic lymphocytic leukemia]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XVnaukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of

lymphoproliferative diseases: materials of the XV scientific and practical conference with international participation. Retrieved from https://www.aoncohem.online/_files/ugd/e1115a_ a8870a0b81ba4c1c92caa67f964884bf.pdf [in Ukrainian].

Tytorenko, I. (2023a). Refrakterni formy KhLL - evoliutsiia khvoroby chy neratsionalne

vykorystannia preparativ khimioterapii? [Refractory forms of CLL - evolution of the disease or irrational use of chemotherapy drugs?]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XV naukovo-praktychnoi konferentsii z

mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XV scientific and practical conference with international participation. Retrieved from https://www.aoncohem.online/_files/ugd/e1115a_a88 70a0b81ba4c1c92caa67f964884bf.pdf [in Ukrainian].

Tytorenko, I.B. (2023b). Unmet needs u vedenni patsiientiv z tsytohenetychnymy anomaliiamy. Chym likuvaty? [Unmet needs in the management of patients with cytogenetic abnormalities. What to treat?]. Diahnostyka khronichnoi limfotsytarnoi leikemii: vebinar mizhnarodnoi shkoly onkohematolohii z profesorom Irynoiu Kriachok - Diagnosis of chronic lymphocytic leukemia: webinar of the International School of Hematology with Professor Iryna Kryachok. Retrieved from https://health-ua.com/article/74948-mzhnarodna-shkola-onkogematolog- zprofesorom-rinoyu-kryachok-dagnostika-hron [in Ukrainian].

Tytorenko, I.B. (2018). Novi mozhlyvosti terapii khronichnoho limfoleikozu [New possibilities of therapy of chronic lymphocytic leukemia]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy VIII naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the VIII scientific and practical conference. Retrieved from https://acclmu.org.ua/wp-content/uploads/2018/04/ProgramA4.jpg [in Ukrainian].

Melnyk, U. (2023). Efekt "povnoho vylikovuvannia" abo bezpechnyi kontrol zakhvoriuvannia protiahom vsoho periodu likuvannia KhLL? [The effect of "complete cure" or safe control of the disease during the entire period of CLL treatment?]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XV naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XV scientific and practical conference with international participation. Retrieved from https://www.aoncohem.online/_files/ugd/e1115a_ a8870a0b81ba4c1c92caa67f964884bf.pdf [in Ukrainian].

Konashenkova, V.V. (2023). Osoblyvosti dyferentsiinoi diahnostyky KhLL: pidvodni kameni imunofenotypuvannia [Features of differential diagnosis of CLL: pitfalls of immunophenotyping]. Diahnostyka khronichnoi limfotsytarnoi leikemii: vebinar mizhnarodnoi shkoly onkohematolohii z profesorom Irynoiu Kriachok - Diagnosis of chronic lymphocytic leukemia: webinar of the International School of Hematology with Professor Iryna Kryachok. Retrieved from https://health-ua.com/article/74948-mzhnarodna-shkola-onkogematolog-zprofesorom- rinoyu-kryachok-dagnostika-hron [in Ukrainian].

Kadnikova, T. (2022). Skhemy likuvannia KhLL z fiksovanoiu tryvalistiu v onovlenomu Klinichnomu protokoli: kombinatsii na osnovi Venetoklaksu [CLL treatment regimens with fixed duration in the updated Clinical Protocol: Venetoclax-based combinations]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XIV naukovo- praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the MV scientific andpractical conference with international participation. [in Ukrainian].

Perekhrestenko, T.P. (2021). Personalizovana terapiia patsiientiv z khronichnoiu limfotsytarnoiu leikemiieiu [Personalized therapy for patients with chronic lymphocytic leukemia]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy ХІІІ naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XIII scientific- practical conference with international participation. Retrieved from https://health-ua.com/ article/68365 -personalzovana-terapya-patcntv-zhronchnoyu-lmfotcitarnoyu-l ej kemyu [in Ukrainian].

Perekhrestenko, T. (2020). Mozhlyvosti i perspektyvy terapii patsiientiv z KhLL [Possibilities and perspectives of therapy for patients with CLL]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XU naukovo- praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XII scientific and practical conference with international participation. Retrieved from https://www.clinicaloncology.com.ua/article/ 28613/daj dzhest-xii-naukovo-praktichno%d 1%97-konferenczi%d 1%97-z-mizhnarodnoyu-uchastyu- suchasni-pidhodi-do-diagnostiki-ta-likuvannya-limfoproliferativnih-zahvoryuvan [in Ukrainian].

Khyts, A.R. (2021). Khronichnyi limfoleikoz: klinichni rekomendatsii ESMO 2020r. [Chronic lymphocytic leukemia: ESMO 2020 clinical guidelines]. Український медичний часопис - Ukraine medical journal, 5 travnia. Retrieved from www.umj.com.ua/uk/publikatsia- 205685-hronichnij-limfolejkoz-klinichni-rekomendatsiyi-esmo-2020-r [in Ukrainian].

Husieva, S.A. (2019a). Stratehiia likuvannia patsiientiv z khronichnym limfotsytarnym leikozom bendamustynom: dani dokazovoi medytsyny [Bendamustine treatment strategy for patients with chronic lymphocytic leukemia: evidence-based medicine]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy IX naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the IX scientific and practical conference. Retrieved from https://health-ua.com/article/43382-strategya-lkuvannya- patcntv-zhronchnim-lmfotcitarnim-lejkozom-dan-dokazovo- [in Ukrainian].

Husieva, S.A. (2019b). Vybir terapii patsiientiv z KhLL [Choice of therapy for patients with CLL]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy IX naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the IX scientific and practical conference. Retrieved from: https ://health- ua.com/article/43388-lkuvannya-hronchnogo-lmfotcitarnogo-lejkozu [in Ukrainian].

Husieva, S.A. (2018). Zastosuvannia pidshkirnoi formy rytuksymabu pry KhLL [Application of the subcutaneous form of rituximab in CLL]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy VIII naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the VIII scientific and practical conference. Retrieved from https://health-ua.com/article/38888-hronchnij- lmfolejkoz-suchasn-mozhlivost-lkuvannya [in Ukrainian].

Mykhalska, L.V. (2019). Terapiia patsiientiv z V-klitynnym KhLL [Therapy of patients with B-cell CLL]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy IX naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the IX scientific and practical conference. Retrieved from https://health-ua.com/article/43388-lkuvannya-hronchnogo-lmfotcitarnogo-lejkozu [in Ukrainian].

Diahil, I.S., Karnabeda, O.A., & Mykhalska, L.V. (2018). Panelna dyskusiia: Portret patsiienta. Vybir taktyky likuvannia pry KhLL [Panel discussion: Portrait of the patient. Choice of treatment tactics for CLL]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy VIII naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the VIII scientific and practical conference. Retrieved from https://health-ua.com/article/38888-hronchnij-lmfolejkoz-suchasn-mozhlivost-lkuvannya [in Ukrainian].

Diahil, I.S. (2018). Praktychni pytannia likuvannia patsiientiv iz KhLL [Practical issues of treatment of patients with CLL]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy VIII naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the VIII scientific and practical conference. Retrieved from https://health-ua.com/article/38888-hronchnij-lmfolejkoz-suchasn-mozhlivost- lkuvannya [in Ukrainian].

Samura, B.B. (2018). Prohnoz kardiovaskuliarnykh podii u patsiientiv pislia likuvannia khronichnoi limfotsytarnoi leikemii [Prediction of cardiovascular events in patients after treatment of chronic lymphocytic leukemia]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy VIII naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the VIII scientific and practical conference. Retrieved from https://acclmu.org.ua/wp-content/uploads/2018/04/ProgramA4.jpg [in Ukrainian].

Martina, Z.V. (2018). Prosuvannia paradyhmy vid likuvannia do zapobihannia [Shifting the paradigm from treatment to prevention]. Perspektyvy diahnostyky ta likuvannia hematolohichnykh zakhvoriuvan: materialy VIII naukovo-praktychnoi konferentsii - Prospects of diagnosis and treatment of hematological diseases: materials of the VIII scientific and practical conference. Retrieved from https://acclmu.org.ua/wp-content/uploads/2018/04/ProgramA4.jpg [in Ukrainian].

Hallek, M. (2015). Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am JHematol, 90 (5), 446-60.

Hallek, M. (2013). Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Blood, Nov 28; 122 (23), 3723-3734.

Hallek, M., Cheson, B.D., & Catovsky, D. et al. (2018). Guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood, 131, 2745-2760. Retrieved from https://www.researchgate.net/publication/323761906_Guidelines_ for_diagnosis_indications_for_treatment_response_assessment_and_supportive_management_of_ chroni c_lymphocyti c_leukemia.

Mansouri, L., Thorvaldsdottir, B., Sutton, L.-A., Karakatsoulis, G., Meggendorfer, M., & Parker, H. et al. (2023). Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on ighv gene somatic hypermutation status: a study by ERIC in harmony. Leukemia, 37, 339-347. Retrieved from https://doi.org/10.1038/s41375-022-01802-y.

Gordon, M.J., & Ferrajoli, A. (2022). Unusual complications in the management of chronic lymphocytic leukemia. Am J Hematol, 97, 26-34. Retrieved from https://pubmed.ncbi.nlm. nih.gov/35491515/.

Agathangelidis, A., Chatzidimitriou, A., Chatzikonstantinou, T., Tresoldi, C., Davis, Z., & Giudicelli, V. et al. (2022). Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC. Leukemia, 36, 1961-1968. Retrieved from https://doi.org/10.1038/s41375-022-01604-2SIX-.

Agathangelidis, A., Chatzidimitriou, A., Gemenetzi, K., Giudicelli, V., Karypidou, M., & Plevova, K. et al. (2021). Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood, Mar 11, 137(10), 1365-1376. Retrieved from https://doi.org/10.1182/blood.2020007039.

Herishanu, Y., Avivi, I., Levi, S., Shefer, G., Bronstein, Y., & Moshiashvili, M. M. et al. (2022). Six-month antibody persistence after bnt162b2 mrna COVID-19 vaccination in patients with chronic lymphocytic leukemia. Blood Adv, Jan 11, 6(1), 148-151. Retrieved from https://doi.org/10.1182/bloodadvances.2021005998.

Baliakas, P., Espinet, B., Mellink, C., Jarosova, M., Athanasiadou, A., & Ghia, P. et al. (2022). Cytogenetics in chronic lymphocytic leukemia: ERIC perspectives and recommendations. Hemasphere, Mar 25, 6(4), 707. Retrieved from https://doi.org/10.1097/HS9.0000000000000707.

Hampel, P.J., & Parikh, S. A. (2022). Chronic lymphocytic leukemia treatment algorithm (2022). Blood Cancer Journal, 12, 161. Retrieved from https://www.nature.com/ articles/s41408-022-00756-9.

Strati, P., Parikh, S.A., Chaffee, K.G., Kay, N.E., Call, T.G., & Achenbach, S.J. et al. (2017). Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study. Br JHaematol, Aug,178(3), 394-402. Retrieved from https://doi.org/10.1111/bjh.14785.

Sutton, L.-A., Ljungstrom, V., Enjuanes, A., Cortese, D., Skaftason, A., & Tausch, E. et al. (2021). Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study. Haematologica, Mar 1,106(3), 682-691. Retrieved from https://doi.org/10.3324/haematol.2019.234716.

Eichhorst, B., Robak, T., & Montserrat, E. et al. (2020). Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 32(1), 23-33. Retrieved from https://doi.org/10.1016/j.annonc.2020.09.019.

Shvidel, L., & Berrebi, A. (2016). Pitting new treatments for chronic lymphocytic leukemia against old ones: how do they fare? Expert Rev Hematol, 9 (3), 245-254.

Dokic, M., Urosevic, I., & Savic, I. et al. (2016). A case of chronic lymphocytic leukaemia occurring during treatment of chronic myeloid leukaemia. Indian J Hematol Blood Transfus, 32 (Suppl 1), 156-158.

Nabhan, C., & Rosen, S.T. (2014). Chronic lymphocytic leukemia: a clinical review. JAMA, 312 (21), 2265-2276.

Mertens, D., & Stilgenbauer, S. (2014). Prognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches? J Clin Oncol, 32 (9), 869-872.

24 konhres Yevropeiskoi hematolohichnoi asotsiatsii (EHA) vidbuvsia 13-16 chervnia v misti Amsterdam. (n. d.). [The 24th Congress of the European Hematology Association (EHA) was held on June 13-16 in Amsterdam]. Retrieved from https://aoncohem.com.ua/24-konhres- evropeiskoi-hematolohichnoi-asotsiatsii-eha-vidbuvsia-13-16-chervnia-v-misti-amsterdam.html [in Ukrainian].

Limfoproliferatyvni zakhvoriuvannia. (n. d.). [Lymphoproliferative diseases]. Retrieved from http://lympho.com.ua/2019/06/10/limfoproliferativni-zahvoryuvannya/ [in Ukrainian].

Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Khronichnyi limfoidnyi leikoz» : Nakaz MOZ Ukrainy «Pro zatverdzhennia ta vprovadzhennia medyko--tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry khronichnomu limfoidnomu leikozi» vid 12.05.2016 r. № 439 [Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care "Chronic lymphoid leukemia" : Order of the Ministry of Health of Ukraine "On the approval and implementation of medical and technological documents on the standardization of medical care for chronic lymphoid leukemia" dated May 12, 2016, No. 439]. Retrieved from https://www.dec.gov.ua/wp-content/uploads/2019/11/2016_439_ykpmd_hll.pdf [in Ukrainian].

Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy: mnozhynna miieloma» : Nakaz MOZ Ukrainy «Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry mnozhynnii miielomi» vid 02.11.2015 r. № 710 [Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care: multiple myeloma : Order of the Ministry of Health of Ukraine "On the approval and implementation of medical and technological documents on the standardization of medical care for multiple myeloma" dated November 2, 2015, No. 710]. Retrieved from https://dec.gov.ua/wp-content/ uploads/images/dodatki/2015_710_MM/2015_710_YKPMD_MM.pdf [in Ukrainian].

Kater, A. (2020). Doslidzhennia MURANO shchodo skhemy zastosuvannia venetoklaksu z rytuksymabom [The MURANO study on the scheme of application of venetoclax with rituximab]. Suchasni pidkhody do diahnostyky ta likuvannia limfoproliferatyvnykh zakhvoriuvan: materialy XII naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu - Modern approaches to the diagnosis and treatment of lymphoproliferative diseases: materials of the XII scientific and practical conference with international participation. Retrieved from https://www.clinicaloncology.com.ua/ article/28613/daj dzhest-xii-naukovo-praktichno%d 1%97-konferenczi%d 1%97-z-mizhnarodnoyu- uchastyu-suchasni-pidhodi-do-diagnostiki-ta-likuvannya-limfoproliferativnih-zahvoryuvan [in Ukrainian].

Размещено на Allbest.Ru/